Drug intelligence / Profile preview

isotretinoin + cholecalciferol

Development stage
Phase 4
Lead developer
Kafrelsheikh University
Modality
Small Molecules
Administration
Inhalation, Intramuscular
01

Overview

This is an investigational combination therapy consisting of aerosolized 13-cis retinoic acid (isotretinoin) and intramuscular cholecalciferol (vitamin D), developed by Kafrelsheikh University. It is specifically designed to treat post-COVID-19 anosmia (loss of smell). The rationale is that SARS-CoV-2 binds to STRA6 receptors, leading to retinol depletion and retinoic acid insufficiency, which prevents the regeneration of olfactory sensory neurons. The treatment aims to upregulate ACE2 and STRA6 receptors and promote the regeneration of olfactory receptors and neurons. It is currently being evaluated in a Phase 4 clinical trial in Egypt.

Other names
13-cis retinoic acid + vitamin Daerosolized 13-cis retinoic acid + cholecalciferolaerosolized retinoic acid + vitamin D
02

Targets

RARA (Retinoic acid receptor alpha)RARG (Retinoic acid receptor gamma)VDR (Vitamin D receptor)ACE2 (Angiotensin-converting enzyme 2)RAR (Retinoic acid receptor)STRA6 (Stimulated by retinoic acid gene 6 protein)

Beyond the preview

Go deeper on isotretinoin + cholecalciferol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isotretinoin + cholecalciferol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call